A Phase 3b Open-label Study to Assess the Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis Subjects with Abnormal Glucose Metabolism.

Project: Research

Project Details

StatusActive
Effective start/end date17/12/20 → 31/12/25

Keywords

  • Cystic fibrosis
  • Respiratory medicine
  • Clinical trial